Novo Nordisk Chooses AWS as Strategic AI Partner for Drug Discovery
Novo Nordisk selected Amazon Web Services as its preferred cloud provider and strategic AI partner, expanding AI use in drug discovery and business operations. The companies will co-develop in a London innovation hub using AWS tools with Novo Nordisk data to speed progress from target identification to human trials, including early research support and clinical trial design. Novo Nordisk says prior collaboration helped reduce clinical documentation time and provided AI tools to over 25,000 employees.